Mexico at a glance
- Population
- 131.9 million 2025
- Life expectancy at birth
- 75.3 years, 2024
- People aged 65 and over
- 8.5 % of people, 2025
- Health spending per person
- 761 US$ per person, 2023
- Doctors
- 2.59 per 1,000 people, 2022
Updated
Reviewed by Chandani Patel
Mexico Neurovascular Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Condition, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$71.1 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $60.4 Mn | — | — |
| 2025 (base) | $65.6 Mn | +$5.1 Mn | — |
| 2026 (forecast) | $71.1 Mn | +$5.6 Mn | +8.5% |
| 2027 (forecast) | $77.2 Mn | +$6.0 Mn | +17.7% |
| 2028 (forecast) | $83.8 Mn | +$6.6 Mn | +27.7% |
| 2029 (forecast) | $90.9 Mn | +$7.1 Mn | +38.6% |
| 2030 (forecast) | $98.6 Mn | +$7.7 Mn | +50.4% |
| 2031 (forecast) | $107.0 Mn | +$8.4 Mn | +63.1% |
| 2032 (forecast) | $116.1 Mn | +$9.1 Mn | +77% |
| 2033 (forecast) | $125.9 Mn | +$9.9 Mn | +92.1% |
| 2034 (forecast) | $136.6 Mn | +$10.7 Mn | +108.4% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $65.6 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $136.6 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 8.5% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, condition and end user (see all) |
| Key players | Stryker, Medtronic, Penumbra, Johnson & Johnson, MicroVention (Terumo) (see all) |
| Regulator in Mexico | COFEPRISSource: COFEPRIS. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Neurovascular devices treat stroke and brain aneurysms through catheters, using clot-removal devices, coils, stents and flow diverters.
Key segments of the neurovascular Devices market include product (Stent Retrievers, Aspiration Catheters and Embolic Coils) and condition (Ischemic Stroke, Brain Aneurysm and AV Malformations).
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the neurovascular Devices market.
Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the neurovascular Devices market strong room to grow.
Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the neurovascular Devices market.
The neurovascular Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices need a sanitary registration from COFEPRIS before sale.[1] Public care comes through IMSS for formal workers, ISSSTE for public employees, and IMSS-Bienestar for people without social security.[2]
[1] COFEPRIS. Checked 14 Nov 2026.
[2] Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how neurovascular Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Mexico.
What doctors and scientists are doing in Neurovascular Devices right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
From our blog
Mexico
Mexico
Mexico
Mexico
Mexico
Mexico
Digital Health · Mexico
Pharmaceuticals · Mexico
Pharmaceuticals · Mexico
Healthcare Services · Mexico
Pharmaceuticals · Mexico
Pharmaceuticals · Mexico